• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Varicose veins associated with higher risk of deep vein thromboses, pulmonary embolisms, and peripheral arterial disease

byDaniel Fisher
March 2, 2018
in Cardiology, Chronic Disease, Emergency, Imaging and Intervention, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this case-control study, patients with varicose veins were at higher risk of deep vein thromboses (DVTs), pulmonary embolisms (PEs), and peripheral arterial disease (PAD).

2. Varicose veins inferred a greater increase in risk in younger patients for DVT and PAD, and men with varicose veins were at higher risk of PAD than women.

Evidence Rating Level: 2 (Good)

Study Rundown: Varicose veins is a highly prevalent disease in adults and is associated with increased inflammation in the vascular system. However, while some smaller cohort studies have tried to estimate the risk of other adverse vascular events and disease, a large cohort study has yet to be completed. In this Taiwanese, case-control cohort study, patients with varicose veins had a higher rate of Deep Vein Thromboses (DVTs), Pulmonary Embolisms (PEs), and Peripheral Arterial Disease (PAD). These results remained significant even when controlling for a number of other co-morbidities and risk factors. For DVT and PAD, varicose veins inferred a greater increase in risk in younger patients, and men with varicose veins were at higher risk of PAD than women. As a negative control, hemangioma was not associated with increased risk of DVT or PE but was associated with a slight decreased risk for PAD. Analysis estimating the potential effects of unmeasured confounders did support a possibility of unknown confounders influencing the association between varicose veins and PE and PAD, but the association with DVT remained robust.

The rigor and large sample size of this study greatly strengthen the conclusions of the study, though some limitations remain. The most important limitation concerns the retrospective nature of the study, and future prospective cohort studies with careful documentation of confounders, especially smoking, would be especially helpful in supporting this study’s conclusions.

Click to read the study, published in JAMA

RELATED REPORTS

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

Reduced-dose apixaban noninferior to full dose for cancer-associated thrombosis

Relevant Reading: Persons With Varicose Veins Have a High Subsequent Incidence of Arterial Disease: A Population-Based Study in Tampere, Finland

In-Depth [case-control]: A total of 212 984 patients were analyzed from the National Health Insurance (NHI) program in Taiwan from 2001 to 2013, with a 4:1 control-to-varicose-vein, age- and sex-matched cohort. Patients were excluded if they were younger than 20 years of age or if they had a diagnosis of DVT, PE, or PAD prior to their varicose vein diagnosis or index date for age-matched controls. Control for the following confounding factors were included in the analysis: sex, age, index year, number of outpatient visits during the year before index date, and comorbidities including hypertension, diabetes, chronic obstructive pulmonary disease, hyperlipidemia, malignancy, heart failure, ischemic heart disease, stroke, and chronic renal insufficiency.

Validation of the varicose vein diagnosis revealed a positive predictive value (PPV) of 98% (CI95 0.95 to 0.99%) with a worse case PPV of 82% (CI95 0.77 to 0.87%). Varicose veins increased the risk of DVT (HR 5.30; CI95 5.05 to 5.56), PE (HR 1.73; CI95 1.54 to 1.94), and PAD (HR 1.72; CI95 1.68 to 1.77). For DVT and PAD, varicose veins inferred a greater increase in risk in younger patients, and men with varicose veins were at higher risk of PAD than women (p < 0.05). As a negative control, hemangioma was not associated with DVT (HR 1.09; CI, 0.99 to 1.20) or PE (HR 1.02; CI95 0.81 to 1.28) but was associated with a decreased risk for PAD (HR CI95 0.78 to 0.86). Analysis for two falsification endpoints, hyperlipidemia and lung cancer, were weakly associated with varicose veins (hyperlipidemia 1.20; CI95 1.19 to 1.22; lung cancer 0.81; CI95 0.76-0.86). Inverse probability of treatment weighting analysis was used to estimate the potential for unmeasured confounders to change risk ratios and supported a possibility of unknown confounders influencing the association between varicose veins and PE and PAD, but the association with DVT remained robust.

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: peripheral artery diseasevaricose veinsvenous thromboembolism
Previous Post

Policy statement outlines ways to improve pediatric medication safety

Next Post

Meropenem-vaborbactam non-inferior to piperacillin-tazobactam for complicated urinary tract infections: The TANGO I trial

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Cardiology

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

April 9, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026
Thrombophilia-associated stillbirth risk appears limited to factor V Leiden
Hematology

Reduced-dose apixaban noninferior to full dose for cancer-associated thrombosis

May 20, 2025
#VisualAbstract: Reduced-Dose was Not Non-Inferior to Full-Dose Direct Oral Anticoagulants in Venous Thromboembolism Patients
StudyGraphics

#VisualAbstract: Reduced-Dose was Not Non-Inferior to Full-Dose Direct Oral Anticoagulants in Venous Thromboembolism Patients

March 10, 2025
Next Post
Rapid growth of medical artificial intelligence technology usage identified from insurance claims analysis, yet major barriers to widespread adoption remain

Meropenem-vaborbactam non-inferior to piperacillin-tazobactam for complicated urinary tract infections: The TANGO I trial

Government-funded initiatives provide important supports to low-income HIV patients

Early diagnosis of HIV infection through analysis of oral fluid [Pre-Clinical]

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

Opioid-related pediatric ICU admissions on the rise over past decade

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Adjuvanted influenza vaccines and high-dose influenza vaccines may have similar effectiveness in adult patients
  • Ambient artificial intelligence scribes reduce clinician documentation time by 16 minutes per encounter
  • Resuscitative endovascular balloon occlusion of the aorta may not improve outcomes in adults with non-traumatic out-of-hospital cardiac arrest
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

The Classics in Medicine Paperback Released!

Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.

amazon-logo_blackGet-it-on-iBooks-badge

Click anywhere to close this announcement

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.